4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001140361-15-013938
CIK 0001069308operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:01 PM ET
Size
10.0 KB
Accession
0001140361-15-013938
Insider Transaction Report
Form 4
Seaman Scott B
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-03-30+71,410→ 71,410 totalExercise: $0.53Exp: 2025-03-30→ Common Stock (71,410 underlying) - Award
Stock Option (Right to Buy)
2015-03-30+35,706→ 35,706 totalExercise: $0.53Exp: 2025-03-30→ Common Stock (35,706 underlying) - Award
Stock Option (Right to Buy)
2015-03-30+23,804→ 23,804 totalExercise: $0.53Exp: 2025-03-30→ Common Stock (23,804 underlying)
Footnotes (3)
- [F1]50% excercisable on grant date of March 30, 2015 and the balance vests on December 31, 2015.
- [F2]50% excercisable on grant date of March 30, 2015 and the balance vests on March 30, 2016.
- [F3]25% vests on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:01 PM ET
- Size
- 10.0 KB